The BLOC1S1 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human SK-HEP-1 hepatic adenocarcinoma cell line, engineered to disrupt the endogenous BLOC1S1 gene. This heterogeneous pool of knockout cells carries targeted modifications at the BLOC1S1 locus, enabling gene function studies without clonal selection bias. Loss of BLOC1S1 allows direct assessment of how the BLOC-1 complex subunit affects lysosome-related organelle biogenesis and vesicular trafficking in an epithelial cancer model. The polyclonal format preserves genetic diversity and reduces clonal adaptation artifacts.
The parental SK-HEP-1 cell line originates from ascites of a patient with liver adenocarcinoma and serves as a widely used hepatocellular carcinoma model. These epithelial cells retain active endolysosomal trafficking and dysregulated mTOR signaling, making them ideal for investigating vesicle transport and organelle maturation in tumor biology. The hepatic adenocarcinoma background further permits evaluation of lysosomal function in cancer-associated processes such as metabolic reprogramming, autophagy, and metastatic behavior.
The BLOC1S1 protein is a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), mediating cargo sorting and vesicle delivery from early endosomes to melanosomes and lysosomes. BLOC1S1 directly interacts with BLOC1S2, BLOC1S3, BLOC1S4, BLOC1S5, and BLOC1S6 to stabilize the complex and facilitate its association with AP-3 adaptor and the SNARE protein VAMP7. This complex functions downstream of nutrient-sensing mTORC1 and the MITF transcription factor, which regulate lysosomal biogenesis genes. BLOC-1 is required for trafficking melanosome cargo proteins like TYRP1; its disruption impairs organelle maturation, lysosomal enzyme sorting, and cellular homeostasis. BLOC1S1 knockout thus provides a definitive loss-of-function model for dissecting BLOC-1-dependent vesicular transport.
In SK-HEP-1 liver adenocarcinoma cells, BLOC1S1 knockout is particularly informative for studying lysosomal trafficking in cancer biology. Lysosomes are integral to nutrient sensing, autophagy, and signal transduction; BLOC-1 disruption may alter mTORC1 activity, lysosomal positioning, and enzyme secretion, influencing tumor cell migration, invasion, and drug resistance. Moreover, because BLOC-1 subunit mutations cause Hermansky-Pudlak syndrome, these polyclonal knockout cells offer a unique isogenic human epithelial model to explore gene-disease associations beyond melanocytic or hematopoietic lineages, while retaining liver-specific organelle dynamics.
The BLOC1S1 Knockout SK-HEP-1 Polyclonal Cells support a wide range of applications. Representative assays include Western blotting for BLOC-1 complex assembly and VAMP7 interaction, immunofluorescence to assess colocalization of organelle markers (e.g., LAMP1, TYRP1), and biochemical measurements of lysosomal enzyme activity. Functional vesicle trafficking assays and cell migration/invasion assays provide direct readouts of trafficking competence and cancer cell behavior. This model facilitates studies in lysosome biogenesis, organelle trafficking, Hermansky-Pudlak syndrome, neurodegeneration, and liver cancer biology. For further details, contact Ascent Research.
